A patient in the clinical trial had a possible liver injury that was no longer a problem once they stopped taking that drug, Pfizer said
For that reason, the present review should be viewed primarily as a critical synthesis of early evidence rather than a basis for definitive therapeutic recommendations
Consequently, we may experience a loss of energy, a decrease in cognitive function, and the visible signs of aging
Its also FDA-approved for androgenetic alopecia (pattern hair loss), so if your GLP-1-related shedding unmasks underlying genetic hair loss, minoxidil addresses both conditions
Walker describes obtaining enteroendocrine cells from the gut
We assume that most who use GLP-1 agonists do not modify diet/lifestyle to create better behaviors, however, I wonder if those on GLP-1 agonists could be clinically at risk of, or are malnourished